Tokyo, Japan, March 30, 2014 --(PR.com
)-- Gerontology Solutions, a pioneering life-sciences start-up concern focused on the development of cutting edge treatments and solutions aimed at combating the aging process in humans has secured unrestricted access to an initial tranche of development funding from Tokyo-based private equity facilitators, Hawk Trade.
“They’ve made some breath-taking advances with their anti-aging treatment, code-named Regenoderm,” said a Hawk Trade spokesperson.
Regenoderm, which seeks to achieve the holy-grail of the cosmetics industry – specifically the growth of regenerative collagen in skin – reportedly, produced “astonishing” results during controlled trials on rodents using a nano-scale deployment of a common compound’s long carbon chain and the peptide of five amino acids attached to one end.
Gerontology Solutions, whose key personnel are Chinese-born biotechnology innovators, has won plaudits for its work from a number of celebrated luminaries within the life-sciences industry. The company says it fully intends to continue its animal based testing until such time as it identifies the most viable solution for humans.
A spokesman for Gerontology Solutions said that the initial funding would go towards the construction of bespoke molecular manipulation equipment for the Regenoderm treatment and provide cash injections for its cancer drug anti-rejection treatment.
Hawk Trade is committing to a funding facility of $35 million to be distributed according to requirements. In return, it will acquire an undisclosed, but likely majority percentage, stake in Gerontology Solutions stock.
“We are excited to be taking this major step with a company that has, so far, been able to so much with so little and look forward to a long and rewarding relationship,” said a Hawk Trade spokesperon.
About Hawk Trade:
Since our inception in 2007, Hawk Trade has focused on delivering exceptional investment performance to our clients both corporate and individual, by coupling entrepreneurial drive with deep industry expertise and robust risk management.
High net worth clients depend on our tailored innovative solutions and on seizing the right opportunities at the most optimum moment. We align ourselves with corporate clients to help them attain all of their capital market requirements.
Our business has grown on the principles of formulating strong partnerships with our clients and maintaining these through integrity and innovation. In the pursuit of excellence for both our firm and our clients, we remain committed to the highest ethical standards.
About Gerontology Solutions:
Gerontology Solutions is dedicated to developing and marketing small-molecule therapeutics derived from genetic and phosphatase platforms and nutritional health supplements that help maintain vigour and functionality as we age.
Through research on protein networks that control biological systems, Gerontology Solutions is developing therapeutic agents for Alzheimer's, Parkinson's and other neurodegenerative diseases. Our technology provides many opportunities for the development of innovative pharmaceutical therapeutics.